ugl semaglutide – julymd Weight-loss drug semaglutide shown to

Focus on keeping food down, staying hydrated, and hitting a minimum protein threshold

W.CarmelietP

doi: 10.1007/S00125-012-2591-4 199 IsaacsSRRoyADanceBWardEJFoskettDBMaxwellAJet al

A GLP1 prescription could indicate: Well-controlled type 2 diabetes Severe obesity under active treatment Metabolic dysfunction associated steatohepatitis (MASH) Obstructive sleep apnea Elevated cardiovascular risk Chronic kidney disease Clinically, those are very different scenarios with very different mortality implications

Tilinca MC, Tiuca RA, Burlacu A, Varga AA (2021) Update on the use of liraglutide in the modern treatment of diabesity: a narrative review

All patient samples were confirmed to carry MUT gene mutations through the standard clinical whole-genome analysis protocol